Articles dans des revues avec comité de lecture (84)
  1. 20. Van Dyck, D., Coquelet, N., Deconinck, N., Aeby, A., Baijot, S., Goldman, S., Urbain, C., Trotta, N., Wens, V., & De Tiege, X. (2020). MEG and high-density EEG resting-state networks mapping in children. Clinical neurophysiology, 131(11), 2713-2715. doi:10.1016/j.clinph.2020.09.003
  2. 21. Albajara Saenz, A., Septier, M., Van Schuerbeek, P., Baijot, S., Deconinck, N., Defresne, P., Delvenne, V., Raeymaekers, H., Victoor, L., Villemonteix, T., Peigneux, P., & Massat, I. (2020). ADHD and ASD: distinct brain patterns of inhibition-related activation? Translational Psychiatry. doi:10.1038/s41398-020-0707-z
  3. 22. Villar-Quiles, R. N., Catervi, F., Cabet, E., Juntas-Morales, R., Genetti, C. C., Gidaro, T., Koparir, A., Yüksel, A., Coppens, S., Deconinck, N., Pierce-Hoffman, E., Lornage, X., Durigneux, J., Laporte, J., Rendu, J., Romero, N. B., Beggs, A. A., Servais, L., Cossée, M., Olivé, M., Böhm, J., Duband-Goulet, I., & Ferreiro, A. (2020). ASC-1 Is a Cell Cycle Regulator Associated with Severe and Mild Forms of Myopathy. Annals of neurology, 87(2), 217-232. doi:10.1002/ana.25660
  4. 23. Carlier, S., Ducenne, L., Leys, C., Stanciu, R., Deconinck, N., Wintgens, A., Oreve, M. J., & Delvenne, V. (2019). Improving autism screening in French-speaking countries: Validation of the Autism Discriminative Tool, a teacher-rated questionnaire for clinicians' use. Research in Autism Spectrum Disorders, 61, 33-44. doi:10.1016/j.rasd.2019.01.010
  5. 24. Aragon-Gawinska, K., Daron, A., Ulinici, A., Vanden Brande, L., Seferian, A. M., Gidaro, T., Scoto, M., Deconinck, N., Servais, L., Benezit, A., Mathieu, M. L., Cances, C., Durigneux, J., Ropars, J., Chouchane, M., Forey, P., Lazaro, L., Hughes, I., Illingworth, M., Marini-Bettolo, C., Cuppen, I., Modrzejewska, S., Balintova, Z., Haberlova, J., Drimtzia, K., Blaschek, A., Ambegankoar, G., & Annoussamy, M. (2019). Sitting in patients with spinal muscular atrophy type 1 treated with nusinersen. Developmental medicine and child neurology, 62(3), 310-314. doi:10.1111/dmcn.14412
  6. 25. Johnson, K., Bertoli, M., Phillips, L., Töpf, A., Van Den Bergh, P., Vissing, J., Witting, N., Nafissi, S., Jamal-Omidi, S., Łusakowska, A., Kostera-Pruszczyk, A., Potulska-Chromik, A., Deconinck, N., Wallgren-Pettersson, C., Strang-Karlsson, S., Colomer, J., Claeys, K. G., De Ridder, W., Baets, J., von der Hagen, M., Fernández-Torrón, R., Zulaica Ijurco, M., Espinal Valencia, J. B., Hahn, A., Durmus, H., Willis, T., Xu, L., Valkanas, E., Mullen, T. T., Lek, M., MacArthur, D. D., & Straub, V. (2018). Detection of variants in dystroglycanopathy-associated genes through the application of targeted whole-exome sequencing analysis to a large cohort of patients with unexplained limb-girdle muscle weakness. Skeletal Muscle, 8(1), 23. doi:10.1186/s13395-018-0170-1
  7. 26. Oates, E. E., Coppens, S., & Deconinck, N. (2018). Congenital Titinopathy: Comprehensive characterization and pathogenic insights. Annals of neurology, 83(6), 1105-1124. doi:10.1002/ana.25241
  8. 27. Paternoster, L., Baijot, S., Deliens, G., Goemans, N., Servais, L., & Deconinck, N. (2018). Cognitive assessment in spinal muscular atrophy type 1-2 using eye tracking system. Neuromuscular disorders, 28(2), 55-56.
  9. 28. Baijot, S., Cevallos Barragan, C., Zarka, D., Leroy, A., Slama, H., Colin, C., Deconinck, N., Danna, B., & Chéron, G. (2017). EEG Dynamics of a Go/Nogo Task in Children with ADHD. Brain sciences, 7(12), 167-182. doi:10.3390/brainsci7120167
  10. 29. Victor, R. G., Sweeney, L. H., Finkel, R. R., Deconinck, N., Byrne, B., Eagle, M., Goemans, N., Vandenborne, K., Dubrovsky, A. A., Topaloglu, H., Miceli, C. M., Furlong, P., Landry, J., Elashoff, R., Cox, D. A., & Tadalafil DMD Study Group, (2017). A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophy. Neurology, 89(17), 1811-1820. doi:10.1212/WNL.0000000000004570
  11. 30. Soblet, J., Dimov, I., Graf von Kalckreuth, C., Cano-Chevrel, J., Baijot, S., Pelc, K., Sottiaux, M., Vilain, C., Smits, G., & Deconinck, N. (2017). BCL11A frameshift mutation associated with dyspraxia and hypotonia affecting the fine, gross, oral, and speech motor systems. American journal of medical genetics. Part A, 176(1), 201-208. doi:10.1002/ajmg.a.38479
  12. 31. Bertini, E., Dessaud, E., Mercuri, E., Muntoni, F., Kirschner, J., Reid, C., Lusakowska, A., Deconinck, N., Cuisset, J. M., Abitbol, J.-L., Scherrer, B., Ducray, P. S., Buchbjerg, J., Vianna, E., van der Pol, L. W., Vuillerot, C., Blaettler, T., Fontoura, P., & Olesoxime SMA Phase 2 Study Investigators, (2017). Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet neurology, 16(7), 513-522. doi:10.1016/S1474-4422(17)30085-6
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 Suivant >>